Risk of major cardiovascular events and all-cause death in patients with bronchiectasis and associated resistance to antimicrobial drugs — Tommaso Bucci (2025) | RDL Network
Risk of major cardiovascular events and all-cause death in patients with bronchiectasis and associated resistance to antimicrobial drugs
Article 2025 en
Authors
TB
Tommaso Bucci
RG
Ran Guo
KY
Kai Hang Yiu
Abstract
1 min read
In patients with bronchiectasis, AMR is associated with an increased risk of MACE and all-cause death, suggesting that controlling AMR spread may confer broader health benefits, particularly in reducing cardiovascular risk.
Yunjeong Kim, S R Lee, Eue-Keun Choi, Hyo‐Jeong Ahn, Nan Young Bae, K Y Lee, Jae-Woon Choi, Hyo‐Jeong Ahn, S I Kwon, Kyungdo Han, Seil Oh, Professor Gregory Lip
L Fauchier, Arnaud Bisson, Alexandre Bodin, Julien Herbert, P Spiesser, Bertrand Pierre, Nicolas Clémenty, D Babuty, Anne Bernard, Professor Gregory Lip
Martin Möckel, Reinhold Müller, Julia Searle, Anna Slagman, Bernard De Bruyne, Patrick W. Serruys, Giora Weisz, Ke Xu, Fabian Holert, Christian Müller, Akiko Maehara, Gregg W. Stone
Discussion(0)
No comments yet. Be the first to comment.